Christine E. MacBrayne
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- HIV/AIDS drug development and treatment 7
- Antimicrobial Resistance in Staphylococcus 5
-
- Streptococcal Infections and Treatments 6
- Co-authors
- Jennifer J. Kiser (8 shared papers)Sarah K. Parker (17 shared papers)Jason Child (6 shared papers)Kelly Pearce (8 shared papers)Amanda L. Hurst (3 shared papers)Peter L. Anderson (4 shared papers)Meghan Birkholz (2 shared papers)Lane R. Bushman (4 shared papers)
- Journals
- Hospital Pediatrics (7 papers)Clinical Infectious Diseases (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)Open Forum Infectious Diseases (2 papers)Diagnosis (2 papers)
- Partner nations
- United StatesBrazilUnited Kingdom
In The Last Decade
Christine E. MacBrayne
33 papers receiving 336 citations
Peers
Comparison fields: 5 of 85
- Applied Microbiology and Biotechnology 70
- Clinical Biochemistry 54
- Hepatology 55
- Infectious Diseases 126
- Pharmacology 79
Countries citing papers authored by Christine E. MacBrayne
This map shows the geographic impact of Christine E. MacBrayne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. MacBrayne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. MacBrayne more than expected).
Fields of papers citing papers by Christine E. MacBrayne
This network shows the impact of papers produced by Christine E. MacBrayne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. MacBrayne. The network helps show where Christine E. MacBrayne may publish in the future.
Co-authors
The 25 scholars most cited alongside Christine E. MacBrayne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 57 | |
| 2 | 2017 | 28 | |
| 3 | 2013 | 26 | |
| 4 | 2021 | 24 | |
| 5 | 2021 | 24 | |
| 6 | 2018 | 17 | |
| 7 | 2016 | 15 | |
| 8 | 2018 | 15 | |
| 9 | 2021 | 14 | |
| 10 | 2019 | 14 | |
| 11 | 2023 | 14 | |
| 12 | 2018 | 13 | |
| 13 | 2014 | 12 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2024 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2020 | 4 | |
| 20 | 2021 | 4 |
About Christine E. MacBrayne
Christine E. MacBrayne is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Applied Microbiology and Biotechnology and Pharmacology, having authored 35 papers that have together received 343 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (9 papers), HIV/AIDS drug development and treatment (7 papers), Streptococcal Infections and Treatments (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Hepatitis C virus research (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (70 citations), Clinical Biochemistry (54 citations), Hepatology (55 citations), Infectious Diseases (126 citations) and Pharmacology (79 citations). Christine E. MacBrayne has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Jennifer J. Kiser, Sarah K. Parker, Jason Child, Kelly Pearce, Amanda L. Hurst, Peter L. Anderson, Meghan Birkholz, Lane R. Bushman, James K. Todd and Joshua Blum. Their work appears in journals such as Hospital Pediatrics, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, Open Forum Infectious Diseases and Diagnosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.